Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection Amjad AlfalehAbdullah AlkattanMona Ibrahim Original Research Article 30 August 2022 Pages: 799 - 806
Reporting of COVID-19 Reinfection and Potential Role of Immunosuppressant/Immunomodulating Agents: A Cross-Sectional Observational Analysis Based on a Spontaneous Reporting Database Elena BeyzarovYan ChenPatrick Caubel Original Research Article Open access 14 September 2022 Pages: 807 - 812
Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan Derar H. Abdel-QaderHasan Abdel-QaderMohammad Asad Original Research Article 23 August 2022 Pages: 813 - 827
Evaluation of the Effect of Uridine Diphosphate-Glucuronosyltransferases (UGT) Inhibition by Valproic Acid on Vixotrigine Pharmacokinetics in Healthy Volunteers Yuan ZhaoMona KotechaHimanshu Naik Original Research Article 31 August 2022 Pages: 829 - 837
Cost-Utility Analysis of CYP2C19 Genotype Detection for Selection of Acid-Suppressive Therapy with Lansoprazole or Vonoprazan for Patients with Reflux Esophagitis in China Zhuolin ZhangYuwen BaoXin Li Original Research Article 22 August 2022 Pages: 839 - 851
Healthcare Utilization of Patients with Opioid Use Disorder in US Hospitals from 2016 to 2019: Focusing on Racial and Regional Variances Sun Jung KimMar MedinaJongwha Chang Original Research Article 24 August 2022 Pages: 853 - 863
Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression Juliana SurjanJulia Diniz GrossiAcioly Luiz Tavares Lacerda Original Research Article 31 August 2022 Pages: 865 - 873
AVT02: An Adalimumab Biosimilar Connie Kang Adis Biosimilar Brief Open access 01 October 2022 Pages: 875 - 878